Back to companies
Cardiff Oncology, Inc.
CRDFUSNASDAQPharmaceuticals & HealthcareCardiff Oncology, Inc.
Revenue
$593,000
YoY -13.2%
Operating income
-$49.0mn
FY2025
Employees
—
Founded
—
Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API